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Abstract
Background: Carotid plaque severity and morphology can affect cardiovascular prognosis.
We evaluate both the importance of echographically assessed carotid artery plaque geometry and
morphology as predictors of death in hospitalised cardiological patients.
Methods: 541 hospitalised patients admitted in a cardiological division (age = 66 ± 11 years, 411
men), have been studied through ultrasound Duplex carotid scan and successively followed-up for
a median of 34 months. Echo evaluation assessed plaque severity and morphology (presence of
heterogeneity and profile).
Results:  361 patients showed carotid stenosis (67% with <50% stenosis, 18% with 50–69%
stenosis, 9% with >70% stenosis, 4% with near occlusion and 2% with total occlusion). During the
follow-up period, there were 83 all-cause deaths (15% of the total population). Using Cox's
proportional hazard model, age (RR 1.06, 95% CI 1.03–1.09, p = 0.000), ejection fraction > 50%
(RR = 0.62, 95% CI 0.4–0.96, p = 0.03), treatment with statins (RR = 0.52, 95% CI 0.29–0.95, p =
0.34) and the presence of a heterogeneous plaque (RR 1.6; 95% CI, 1.2 to 2.14, p = 0.002) were
independent predictors of death. Kaplan – Meier survival estimates have shown the best outcome
in patients without plaque, intermediate in patients with homogeneous plaques and the worst
outcome in patients with heterogeneous plaques (90% vs 79% vs 73%, p = 0.0001).
Conclusion:  In hospitalised cardiological patients, carotid plaque presence and morphology
assessed by ultrasound are independent predictors of death.
Background
Non-invasive carotid artery ultrasound is a well estab-
lished and valid method which allows to both visualize
and quantify atherosclerotic lesions. Ultrasound and
autopsy studies have shown that the presence and extent
of carotid atherosclerosis correlates with atherosclerosis
elsewhere in the circulation, including coronary arteries
[1-4]. Several studies have found that the presence of
carotid stenosis is a strong predictor of death in the gen-
eral population [5,6].
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Moreover, there is evidence that ultrasonographic B-mode
characterization of plaque morphology may be useful in
the assessment of the vulnerability of the atherosclerotic
lesions [7-10].
Atherosclerotic plaque composition appears to be more
important than plaque size in determining adverse events
[11]. In particular, lipids and haemorrhages are associated
with a more active plaque [12,13], which appear to be
more vulnerable to rupture. Ultrasonically assessed
plaque morphology provides an insight into the plaque
composition and structure as shown by both in vitro [14-
18] and in vivo [19-23] studies. Echo-lucent carotid
plaques are lipid-rich and have a greater potential for clin-
ical complications [7,10]. Heterogeneous plaques have a
hypoechoic component and are associated with the pres-
ence of intra-plaque haemorrhage, ulceration and lipids,
more likely to result in adverse events [8,21,22].
The purpose of the present study has been to show the
importance of echographically assessed carotid artery
plaque geometry and morphology as predictors of death
in hospitalised cardiological patients.
Methods
Patient population
The present study is a single-centre prospective study of
the outcome of in-hospital cardiological patients referred
to the Cardiology Division of the Institute of Clinical
Physiology, CNR, Pisa.
We enrolled 541 in-hospital patients (age = 66 ± 11 years;
411 men) which have been admitted to our cardiological
division with a diagnosis, at admission, of: ischemic heart
disease (64%), cardiomyopathy (6%), valvular heart dis-
ease (8%), arrythymias (9%) and miscellaneous (13%).
Patients were followed for a median of 34 months; our
end-point was the occurrence of death.
Baseline evaluation included a complete history and
physical examination which has been performed by a car-
diologist, with information regarding: family history,
hypertension (blood pressure ≥ 140/90 mmHg based on
the average of repeated readings or patients on antihyper-
tensive drugs), hypercholesterolemia (total cholesterol >
200 mg/dl and/or trigliceridemia > 150 mg/dl or patient
on lipid lowering therapy), diabetes mellitus (controlled
with diet; oral hypoglycemic agents, or insulin; or fasting
glucose level ≥ 126 mg/dl), obesity (body mass index ≥
30), smoking habits (never smokers; smokers who
stopped smoking one month before hospitalisation and
current smokers), presence or previous history of coronary
artery disease (prevalent angina pectoris, documented
previous or current documented acute coronary ischemia
or angiographically documented coronary artery steno-
sis).
Ultrasound examination
Colour duplex carotid artery scan has been performed by
5 operators with commercially available ultrasound sys-
tems (Phillips SONOS 5500, Acuson Sequoia 512,
Vingmed System Five). High resolution B-mode, colour
Doppler and pulsed-wave Doppler, for both of the carotid
arteries, have been performed with an ultrasound linear-
array 5 – 10 MHz transducer. Patients have been scanned
in a supine position. All of the exams have been stored on
s-VHS tapes, recorded from different transducer positions
and angles (longitudinal and cross-sectional images) in
order to document representative plaque geometry and
morphology.
Assessment of plaque severity
At the initial evaluation, colour duplex scan has been per-
formed on both the right and left common and internal
carotid arteries. Categories of carotid stenosis (expressed
as the percentage decrease in artery diameter) have been
defined on the basis of the B-mode and on velocity crite-
ria: internal carotid artery peak systolic velocity (PSV),
end-diastolic velocity (EDV), and internal carotid artery /
common carotid artery PSV ratio. According to the latest
consensus for Doppler ultrasound criteria for the diagno-
sis of internal carotid artery stenosis, the degree of stenosis
have been classified [23]. In particular, a non-significant
(<50%) stenosis has been identified by a peak systolic
velocity <125 cm/sec, and a stenosis ≥ 70% by a peak
systolic velocity ≥ 230 cm/sec. In the case of bilateral ste-
nosis or multiple plaques, the carotid plaque with the
highest degree of stenosis have been selected for analysis.
Assessment of plaque morphology
Plaque were defined as a localized protrusion of the vessel
wall into the lumen with an area 50% greater than the
intima-media thickness of neighbouring sites on visual
assessment [24]. Plaque morphology, in terms of echo-
genicity, were characterized according to a modified ver-
sion of the classification proposed by Gray- Weale [25].
Plaque echogenicity have been graded into two broad cat-
egories: low and high. Low echogenic plaques are black as
blood or predominantly black (echolucent), while high
echogenic plaques are predominantly white, similar to
far-wall adventitia interface (echo-rich or echogenic).
Plaques have been classified according to their structural
appearance being either heterogeneous or homogeneous.
Plaques have been characterized as heterogeneous, if the
echogenicity of more than 20% of the plaque differed
from the echogenicity of the rest of the plaque by two or
more echogenicity grades [26]. We also assessed the
plaque surface morphology, classifying it as regular
(smooth) or irregular. The plaque surface appearance hasCardiovascular Ultrasound 2006, 4:16 http://www.cardiovascularultrasound.com/content/4/1/16
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been defined as irregular when height variations between
0.4 and 2 mm appeared to be present along the contour
of the lesion [27].
Follow-up data
Follow-up data have been obtained for all of the patients.
Total mortality has been the primary end point [28]. Both
hospital and physician records, and death certificates,
have been used to ascertain the final presentation.
Statistical analysis
Differences in continuous and categorical variables have
been evaluated through the Student t test (two-tailed) for
unpaired values and the chi-square test, respectively. Cox
proportional-hazard regression model have been per-
formed in order to describe the relationship between the
dependent variable (death) and several clinical and echo-
graphic parameters, including age, gender, hypertension,
diabetes, hypercholesterolemia, plaque morphology and
percent stenosis. The Kaplan-Meier method has been used
for the survival analysis. All statistical tests have been per-
formed with the SPSS program, version 11.0. Probability
values of p < 0.05 have been considered to be significant.
The variability between observer has been analysed by
using the kappa statistic (κ). κ measures the agreement
that occurs above chance and may have values between -1
(complete disagreement) and +1 (perfect agreement). κ
values from 0 to 0.20 are categorized as light agreement,
those from 0.21 to 0.40 as fair, those from 0.41 to 0.60 as
moderate, those from 0.61 to 0.80 as substantial, and
those above 0.80 as almost perfect agreement [29].
Results
361 (67%) of the 541 patients presented a carotid plaque.
Baseline clinical characteristics of the patient population
separated on the basis of carotid plaque presence, are
shown in Table 1. Patients with carotid plaque were older,
presented a higher prevalence of diabetes and hyperten-
sion and appeared to have a higher prevalence of coronary
artery disease and angina at admission.
Ultrasonographic data
The between-observer agreement on plaque morphology
has been evaluated separately on a set of 30 consecutive
plaques. The inter-observer agreement appeared to be
substantial with a κ value of 0.72 (95% CI = 0.53–0.86)
for heterogeneity and 0.76 (95% CI 0.56–0.88) for pro-
file. 220 (61%) of the 361 patients with plaque, presented
a heterogeneous and 108 ones (30%) an irregular plaque
and 75 (20%) presented both criteria. Regarding the sten-
osis degree, 243 (67.3%) patients presented < 50% steno-
sis, 66 (18.2%) patients 50–69% stenosis, 32 (8.8%)
patients ≥ 70% stenosis, 14 (3.8%) patients presented a
near occlusion and 6 (1.6%) patients presented occlusion
of carotid artery.
The relative prognostic value of clinical and echographic
variables
Patients were followed for a median of 34 months. During
the follow-up period there were 83 all-cause death (15%
of the total population); death was attributed to cardio-
vascular causes in 58 patients (70%). Univariate predic-
tors of total mortality are reported in Table 2. Kaplan-
Meier survival estimates for total mortality showed a bet-
ter outcome for those with no carotid artery stenosis com-
pared to those with the presence of carotid stenosis as a
function of stenosis severity, the worst outcome is in the
subgroup with near occlusion or occlusion (log rank
19.25, p < 0.0007): Figure 1. With Cox's proportional haz-
ard model analysis independent predictors of death were:
age (RR 1.06, 95% CI 1.03–1.09, p = 0.000), and the pres-
ence of a heterogeneous plaque (RR 1.6; 95% CI, 1.2 to
2.14, p = 0.002), whereas a normal ejection fraction (RR =
Table 1: Clinical characteristics of patients with and without plaque
All (n = 541) Absence of plaque (n = 180) Presence of plaque (n = 361) p
Age, y 66 ± 10.9 61.7 ± 12.6 68.7 ± 9.2 <0.001
Males 411 (76%) 134 (74.4%) 277 (76.7%) 0.59
Diabetes 112 (20.7%) 28 (15.6%) 84 (23.3%) 0.04
Hypertension 290 (53.6%) 77 (42.8%) 213 (59%) <0.001
Hypercholesterolemia 310 (57%) 111 (61%) 199 (55%) 0.16
Hypertrigliceridemia 131 (24.2%) 49 (27.2%) 82 (22.7%) 0.28
Obesity 135 (25%) 47 (26.1%) 88 (24.4%) 0.67
Angina at admission 338 (62.5%) 101 (56.1%) 237 (65.7%) 0.03
Ejection fraction <50% 141(26.1%) 35 (19.4%) 106 (29.4%) 0.01
Treatment
Statins 163 (30%) 49 (27%) 114 (31%) 0.31
Beta-blockers 157 (29%) 48 (26%) 109 (30 %) 0.42
Antiplatelet-agents 376 (70%) 113 (62 %) 263 (73%) 0.018
ACE inhibitors 133 (25%) 32 (17%) 101 (28%) 0.011
Nitrate 323 (60%) 88 (48%) 235 (65%) 0.000Cardiovascular Ultrasound 2006, 4:16 http://www.cardiovascularultrasound.com/content/4/1/16
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0.62, 95% CI 0.4–0.96, p = 0.03) and treatment with stat-
ins (RR = 0.52, 95% CI 0.29–0.95, p = 0.34) were associ-
ated with a lower risk for all cause death (Table 3).
Kaplan-Meier survival estimates have shown the best out-
come in patients without plaque, intermediate outcome
in patients with homogeneous plaques, and the worst
outcome in patients with heterogeneous plaques (90% vs
79% vs 73%, p = 0.0001) (Figure 2).
Discussion
In hospitalised cardiological patients, carotid plaque pres-
ence and morphology assessed by ultrasound are inde-
pendent predictors of death. For any given level of
stenosis heterogeneous and/or hypoechoic plaque texture
is associated with a worse outcome, as shown in the
carotid [7,8,30,31], coronary [32] and aortic [33] district
by transcutaneous, intravascular and transesophageal
echocardiography, respectively.
Plaque histology, biological activity and ultrasound
New understanding of the pathophysiology of atheroscle-
rotic disease has shown that high grade coronary or
carotid lesions are not strictly associated with the site of
future occlusions [11]. From histopathologic and vascular
biologic studies, plaque composition and vulnerability
(type of lesion) rather than degree of stenosis (size of
lesion), have emerged as crucial factors leading to sudden
rupture of the plaque surface, usually with superimposed
thrombosis, which underlies the majority of acute occlu-
sions [12]. Homogeneous plaques have been correlated
with a fibrous lesion on pathological examination and the
heterogeneous plaques have been correlated with the
presence of intra-plaque haemorrhage, ulceration and
loose stroma containing lipids, cholesterol and proteina-
ceous deposits [22]. Echo-lucency is associated with lipid-
rich plaques [34]. All of the heterogeneous plaques have a
echo-lucent component but with B-mode assessment we
cannot determine whether echolucent material really rep-
resents lipid, haemorrhage, thrombi. A hypo-echoic
appearance can also be associated with intra-plaque
haemorrhage, which may be the result of intra-plaque
neo-vascularization. These small, fragile vessels could rep-
resent the underlying anatomic and pathologic changes
leading to intramural haemorrhages and rupture. Lipid
lakes and intra-plaque haemorrhage are more frequently
found in vulnerable plaques, with greater potential for
evolution and complication, and are the dominant sub-
strate of hypoechoic and heterogeneous plaques [13].
Table 2: Univariate predictors of death
Variable p value RR (95% CI)
Male gender 0.10 0.62 (0.35–1.10)
Age 0.000 1.07 (1.04–1.10)
Coronary artery disease 0.82 0.95 (0.59–1.51)
Ejection fraction >50% 0.009 0.55 (0.35–0.86)
Diabetes 0.19 1.39 (0.84–2.28)
Hypercholesterolemia 0.21 0.70 (0.40–1.17)
Hypertension 0.6 0.89 (0.58–1.37)
Obesity 0.17 0.68 (0.39–1.18)
Presence of Carotid plaque 0.000 2.91 (1.61–5.27)
Heterogeneity 0.000 1.80 (1.36–2.39)
Irregular profile 0.000 1.79 (1.33–2.42)
High degree of stenosis 0.000 1.01 (1.00–1.02)
Treatment
Statins 0.005 0.45 (0.24–0.77)
Beta-blockers 0.26 0.75 (0.45–1.24)
Antiplatelet-agents 0.43 0.83 (0.52–1.31)
ACE inhibitors 0.65 1.12 (0.69–1.82)
Nitrate 0.17 1.39 (0.87–2.22)
Table 3: Multivariate predictors of death
Variable P RR (95% CI)
FE > 50% 0.03 0.62 (0.40–0.96)
Age 0.000 1.06 (1.03–1.09)
Heterogeneity 0.002 1.6 (1.20–2.14)
Statins 0.03 0.52 (0.29–0.95)Cardiovascular Ultrasound 2006, 4:16 http://www.cardiovascularultrasound.com/content/4/1/16
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Carotid plaque morphology as an index of clinical 
instability
It is generally agreed that ultrasonic assessment of plaque
morphology – in addition to the degree of stenosis – is a
predictor of the prognosis, identifying plaques at a higher
risk of becoming clinically symptomatic. Subjects with
echo-lucent atherosclerotic plaques have increased risk of
ischemic cerebrovascular events independently of both
degree of stenosis and cardiovascular risk factors [7,31].
Heterogeneous plaques are associated with a higher inci-
dence of cerebrovascular symptoms than homogeneous
plaques for all grades of stenosis [8]. The link between
echo plaque structure and prognosis do not appear to be
limited to the carotid arteries but may apply to virtually all
vascular districts where atherosclerotic plaques can be
imaged by ultrasound technology. In coronary arteries,
echo-lucent zones by intra-vascular ultrasound are also at
increased risk of clinical instability [32]. In the ascending
thoracic aorta, non-calcified aortic plaques detected by
TEE in brain infarction have been associated with a 10-
fold increased risk of subsequent events when compared
to calcified plaque [33]. Recent studies support the con-
cept that plaque instability is not merely a local vascular
incident but rather that plaque instability exists simulta-
neously at multiple sites of the vascular bed [35]. Honda
et al [10] have demonstrated (using radiofrequency anal-
ysis) that echo-lucent carotid plaques predict the presence
of complex coronary plaques and the development of
future coronary complications in stable coronary artery
diseased patients. If carotid and coronary artery plaques
share common morphological characteristics within indi-
viduals, then the ultrasound of the carotid artery may be a
simple, non-invasive test to screen asymptomatic subjects
at high risk of cardiovascular events.
Survival free of event (death) as a function of severity of stenosis Figure 1
Survival free of event (death) as a function of severity of stenosis. Numbers of patients at risk are listed below each group. 
Patients without plaque +; < 50% stenosis O; 50–69% stenosis ; ≥ 70% stenosis ; near occlusion and occlusion ∆.Cardiovascular Ultrasound 2006, 4:16 http://www.cardiovascularultrasound.com/content/4/1/16
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Study limitations
Today, ultrasound tissue characterization may be per-
formed by using three methods: subjective assessment (a
visual and qualitative analysis of video B-mode image),
video densitometry (a quantitative analysis of video
image) and acoustic densitometry (a quantitative analysis
of unfiltered radio-frequency signal before the video
processing chain).
The B-mode assessment can offer a qualitative informa-
tion about tissue characterization but without precision
and with a moderate-to-good agreement between and
within-observers [8,26,30,36]. Visual morphological
characterization of the carotid plaque correlates well with
histological features [37]. This apparently simple method,
has been adopted in the present study but it is based on
subjective judgment and is operator-dependent.
A videodensitometric [34,38] or – even more – a radiofre-
quency-based [39-41] approach would have certainly
granted a more quantitative, albeit more technologically
demanding, approach. Nevertheless, the visual assess-
ment of plaque echogenicity and heterogeneity correlates
well with the videodensitometric assessment of gray-scale
value and the visual evaluation of carotid plaque remains
therefore a valuable method in daily clinical practice [42].
However, there is little doubt that more quantitative,
operator-independent criteria would allow the clinician
to place the information on plaque morphology on a
more solid and reliable basis.
Conclusion
Ultrasound-based assessment of carotid plaque presence
and morphology are independent predictors of death in
hospitalised cardiological patients. The present study sug-
Survival free of event (death) as a function of presence of heterogeneous plaque Figure 2
Survival free of event (death) as a function of presence of heterogeneous plaque. Numbers at risk are listed below each group.Cardiovascular Ultrasound 2006, 4:16 http://www.cardiovascularultrasound.com/content/4/1/16
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gests that the assessment of plaque morphology is more
important than plaque size as an indicator of prognosis.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
CP participated in the design and coordination of the
manuscript, and in the patients enrollment, performed
the statistical analysis and wrote the paper. PP partici-
pated in the statistical analysis and wrote the paper. LV
participated in the patients enrollment and gave critical
intellectual suggestions. EmP participated in the patients
enrollment and gave critical intellectual suggestions.
LP participated in the patients enrollment and gave criti-
cal intellectual suggestions.
E P participated in its design and coordination and was
the overall supervisor of the paper. All authors read and
approved the final manuscript.
References
1. Solberg LA, McGarry PA, Moossy J, Strong JP, Tejada C, Loken AC:
Severity of atherosclerosis in cerebral arteries, coronaty
arteries, and aortas.  Ann NY Acad Sci 1968, 149:956-973.
2. Pancioli AM, Broderick J, Kothari R, Tuchfaber A, Miller R, Khoury J,
Jauch : Public perceptions of stroke warning signs and knowl-
edge of potential risk factors.  JAMA 1998, 279:1288-1292.
3. Craven T, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, Mc
Mahan MR, Thompson CJ, Heiss G, Crouse JR: Evaluation of the
associations between carotid artery atherosclerosis and cor-
onary artery stenosis: a case-control study.  Circulation 1990,
82:1288-1292.
4. Kallikazaros I, Tsioufis C, Sideris S, Stefanadis C, Toutouzas P:
Carotid artery disease as a marker for presence of severe
coronary artery disease in patients evaluated for chest pain.
Stroke 1999, 30:1002-1007.
5. Lerfeldt B, Forsberg M, Blomstrand C, Mellström D, Volkmann R:
Cerebral Atherosclerosis as Predictor of Stroke and Mortal-
ity in Representative Elderly Population.  Stroke 2002,
33:224-229.
6. Joakimsen O, Bønaa KH, Mathiesen EB, Strenland-Bugge E, Arnesen
E: Prediction of mortality by ultrasound screening of a gen-
eral population for carotid stenosis. The Tromsø Study.
Stroke 2000, 31:1871-1876.
7. Gronholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen
H:  Ultrasonic echolucent carotid plaques predict future
strokes.  Circulation 2001, 104:68-73.
8. AbuRahma AF, Wulu JT Jr, Crotty B: Carotid plaque ultrasonic
heterogeneity and severity of stenosis.  Stroke 2002,
33:1772-1775.
9. Liapis CD, Kakisis JD, Kostakis AG: Carotid stenosis. Factors
affecting symptomatology.  Stroke 2001, 32:2782-2786.
10. Honda O, Sugiyama S, Kugiyama , Fukushima H, Nakamura S, Koide
S, Kojima S, Hirai N, Kawano H, Soejima H, Sakamoto T, Yoshimura
M, Ogawa H: Echolucent carotid Plaques predict future coro-
nary events in patients with coronary artery disease.  J Am Coll
Cardiol 2004, 43:1177-1184.
11. Falk E: Why do plaques rupture?  Circulation 1992, 86:30-42.
12. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis
of coronary artery disease and the acute coronary syn-
dromes.  N Engl J Med 1992, 326:310-8.
13. Davies MJ: Stability and instability: two faces of coronary
atherosclerosis. The Paul Dudley White Lecture 1995.  Circu-
lation 1996, 94:2013-2020.
14. Picano E, Landini L, Distante A, Sarnelli R, Benassi A, L'Abbate A: Dif-
ferent degrees of atherosclerosis detected by backscattered
ultrasound: an in vitro study on fixed human aortic walls.  J
Clin Ultrasound 1983, 11:375-379.
15. Picano E, Landini L, Distante A, Salvadori M, Lattanzi F, Masini M,
L'Abbate A: Angle dependence of ultrasonic backscatter in
arterial tissues: a study in vitro.  Circulation 1985, 72:572-576.
16. Picano E, Landini L, Distante A, Benassi A, Sarnelli R, L'Abbate A:
Fibrosis, Lipids and Calcium in Human Atherosclerotic
Plaque. In Vitro Differentiation from Normal Aortic Walls
by Ultrasonic Attenuation.  Circ Res 1985, 56:556-562.
17. Picano E, Landini L, Lattanzi F, Mazzarisi A, Sarnelli R, Distante A,
Benassi A, L'Abbate A: The use of frequency histograms of
ultrasonic backscatter amplitudes for the detection of
atherosclerosis in vitro.  Circulation 1986, 74:093-1098.
18. Picano E, Landini L, Lattanzi F, Salvadori M, Benassi A, L'Abbate A:
Time domain echo pattern evaluation from normal and
atherosclerotic arterial walls: a study in vitro.  Circulation 1988,
77:654-59.
19. Urbani MP, Picano E, Parenti G, Mazzarisi A, Fiori L, Paterni M, Pelosi
G, Landini L: In vivo radiofrequency-based ultrasonic tissue
characterization of the atherosclerotic plaque.  Stroke 1993,
24:1507-1512.
20. Kawasaki M, Takatsu H, Noda T, Ito Y, Kunishima A, Arai M, Nishigaki
K, Takemura G, Morita N, Minatoguchi S, Fujiwara H: Non invasive
quantitative tissue characterization and two-dimensional
color-coded map of human atherosclerotic lesions using
ultrasound integrated backscatter. Comparison between
histology and integrated backscatter images before and
after death.  J Am Coll Cardiol 2001, 38:486-492.
21. Abu Rahma AF, Kyer PD, Robinson PA, Hannay RS: The correlation
of ultrasonic plaque morphology and carotid plaque hemor-
rhage: clinical implications.  Surgery 1998, 124:721-728.
22. Reilly LM, Lusby RJ, Hughes L, Ferrell LD, Stonley RJ, Ehrenfeld WK:
Carotid plaque histology using real-time ultrasonography:
clinical and therapeutic implications.  Am J Surg 1983,
146:188-193.
23. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth
EI, Carroll I, Eliaziw M, Gocke J, Hertzberg BS, Katanick S, Needleman
L, Pellerito J, Polak J, Rholl KS, Wooster DL, Zierler R: Society of
radiologists in ultrasound consensus conference. Carotid
Artery stenosis : Gray scale and Doppler US diagnosis.  Radi-
ology 2003, 229:340-346.
24. Schmidt C, Fagerberg B, Wirkstrand J, Hulthe J, on behalf of the Ris
study group: Multiple risk factor intervention reduces cardio-
vascular risk in hypertensive patients with echolucent
plaques in the carotid artery.  J Intern Med 2003, 253:430-438.
25. Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ: Carotid
artery atheroma: comparison of preoperative B-mode ultra-
sound appearance with carotid endarterectomy specimen
pathology.  J Cardiovasc Surg 1988, 29:676-681.
26. Joakimsen O, Bøona KH, Stensland-Bugge E: Reproducibility of
ultrasound assessment of carotid plaque occurrence, thick-
ness, and morphology. The Tromsø study.  Stroke 1997,
28:2201-2207.
27. Kern R, Szabo K, Hennerici M, Meairs S: Plaque characterization
using compound ultrasound.  Stroke 2004, 35:870-875.
28. Lauer MS, Blackstone EH, Young JB, Topol EJ: Cause of death in
clinical research: time for a reassessment ?  J Am Coll Cardiol
1999, 34:618-620.
29. Bland J, Altman D: Statistical methods for assessing agreement
between two methods of clinical measurements.  Lancet
1986:307-310.
30. Liapis CD, Kakisis JD, Dimitroulis DA, Daskalopoulos M, Nikolaou A,
Kostakis AG: Carotid ultrasound findings as a predictor of
long-term survival after abdominal aortic aneurysm repair:
a 14-year prospective study.  J Vasc Surg 2003, 38:1220-1225.
31. Mathiesen EB, B∅onaa KH, Joakimsen O: Echolucent plaques are
associated with high risk of ischemic cerebrovascular events
in carotid stenosis.  Circulation 2001, 103:2171-2175.
32. Yamagishi M, Terashima M, Awano K, Kijima N, Nakatani S, Daikoku
S, Ito K, Yasumura Y, Miyatake K: Morphology of vulnerable cor-
onary plaque: insights from follow-up of patients examined
by intravascular ultrasound before an acute coronary syn-
drome.  J Am Coll Cardiol 2000, 35:106-111.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cardiovascular Ultrasound 2006, 4:16 http://www.cardiovascularultrasound.com/content/4/1/16
Page 8 of 8
(page number not for citation purposes)
33. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG, Amarenco
P: Aortic plaque morphology and vascular events: a follow-up
study in patients with ischemic stroke. FAPS Investigators.
French Study of Aortic Plaques in Stroke.  Circulation 1997,
96:3838-3841.
34. Grønholdt MLM, Nordestgaard B, Nielsen TG, Sillesen H: Echolu-
cent carotid plaques are associated with elevated levels of
fasting and postprandial tryglycerides -rich lipoproteins.
Stroke 1996, 27:2166-2172.
35. Rothwell PM, Villagra R, Gibson R, Donders RC, Warlow CP: Evi-
dence of a chronic systemic cause of instability of atheroscle-
rotic plaques.  Lancet 2000, 355:19-24.
36. El-Barghouty NM, Levine T, Ladva S, et al.: Histological verification
of computerized carotid plaque characterization.  Eur J Vasc
Endovasc Surg 1996, 11:414-416.
37. Gronholdt MLM: Ultrasound and lipoproteins as predictors of
lipid-rich, rupture-prone plaques in the carotid artery.  Arteri-
oscler Thromb Vasc Biol 1999, 19:2-13.
38. Biasi GM, Froio AF, Diethrich EB, Deleo G, Galimberti S, Mingazzini
P, Nicolaides AN, Griffin M, Raithel D, Reid DB, Valsecchi MG:
Carotid plaque echolucency increases the risk of stroke in
carotid stenting. The imaging in carotid angioplsty and risk
of stroke (ICAROS) study.  Circulation 2004, 110:756-762.
39. Elatrozy T, Nicolaides A, Tegos T, Zarka AZ, Griffin M, Sebetai M:
The effect of B-mode ultrasonic image standardization on
the echodensity of symptomatic and assymptomatic carotid
bifurcation plaques.  Int Angiol 1998, 17:179-186.
40. Sabetai MM, Tegos TJ, Nicolaides AN, Dhangil S, Pare GJ, Stevens JM:
Reproducibility of computer-quantified carotid plaque echo-
genicity: can we overcome the subjectivity?  Stroke 2000,
31:2189-2196.
41. Takiuchi S, Rakugi H, Honda K, Masuyama T, Hirata N, Ito H, Sugim-
oto K, Yanagitani , Moriguchi K, Okamura A, Higaki J, Ogihara T:
Quantitative ultrasonic tissue characterization can identify
high-risk atherosclerotic alteration in human carotid arter-
ies.  Circulation 2000, 102:766-770.
42. Mayor I, Momjian S, Lalive P, Sztajzel R: Carotid plaque: compari-
son between visual and grey-scale median analysis.  Ultrasound
Med Biol 2003, 29:961-966.